Logo image of NOM

NUVEEN MO QLTY MUNI INC (NOM) Stock Price, Quote, News and Overview

NYSE:NOM - New York Stock Exchange, Inc. - US67060Q1085 - Currency: USD

11.26  +0.56 (+5.23%)

After market: 11.7 +0.44 (+3.91%)

Fundamental Rating

1

NOM gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. NOM has a bad profitability rating. Also its financial health evaluation is rather negative. NOM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year NOM was profitable.
In the past year NOM had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: NOM reported negative net income in multiple years.
Of the past 5 years NOM 4 years had a positive operating cash flow.
NOM Yearly Net Income VS EBIT VS OCF VS FCFNOM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M

1.2 Ratios

Industry RankSector Rank
ROA 3.48%
ROE 5.93%
ROIC 1.12%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NOM Yearly ROA, ROE, ROICNOM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

In the last couple of years the Profit Margin of NOM has declined.
In the last couple of years the Operating Margin of NOM has declined.
NOM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 33.16%
PM (TTM) 81.63%
GM 36.22%
OM growth 3Y-18.54%
OM growth 5Y-9.1%
PM growth 3Y-29.59%
PM growth 5Y-15.05%
GM growth 3Y-17.51%
GM growth 5Y-8.59%
NOM Yearly Profit, Operating, Gross MarginsNOM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

1

2. Health

2.1 Basic Checks

There is no outstanding debt for NOM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NOM Yearly Shares OutstandingNOM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M
NOM Yearly Total Debt VS Total AssetsNOM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of 1.70, we must say that NOM is in the distress zone and has some risk of bankruptcy.
NOM has a debt to FCF ratio of 9.55. This is a negative value and a sign of low solvency as NOM would need 9.55 years to pay back of all of its debts.
A Debt/Equity ratio of 0.67 indicates that NOM is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 9.55
Altman-Z 1.7
ROIC/WACCN/A
WACCN/A
NOM Yearly LT Debt VS Equity VS FCFNOM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 0.43 indicates that NOM may have some problems paying its short term obligations.
A Quick Ratio of 0.43 indicates that NOM may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.43
NOM Yearly Current Assets VS Current LiabilitesNOM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.89% over the past year.
Measured over the past years, NOM shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.18% on average per year.
Looking at the last year, NOM shows a small growth in Revenue. The Revenue has grown by 2.41% in the last year.
The Revenue has been decreasing by -1.28% on average over the past years.
EPS 1Y (TTM)88.89%
EPS 3Y-29.56%
EPS 5Y-16.18%
EPS Q2Q%133.33%
Revenue 1Y (TTM)2.41%
Revenue growth 3Y0.34%
Revenue growth 5Y-1.28%
Sales Q2Q%1.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NOM Yearly Revenue VS EstimatesNOM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.56, NOM is valued correctly.
Compared to an average S&P500 Price/Earnings ratio of 27.19, NOM is valued a bit cheaper.
Industry RankSector Rank
PE 16.56
Fwd PE N/A
NOM Price Earnings VS Forward Price EarningsNOM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 13.3
EV/EBITDA N/A
NOM Per share dataNOM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.57%, NOM is a good candidate for dividend investing.
NOM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 7.57%

5.2 History

NOM has been paying a dividend for at least 10 years, so it has a reliable track record.
NOM has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
NOM Yearly Dividends per shareNOM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

NOM pays out 85.63% of its income as dividend. This is not a sustainable payout ratio.
DP85.63%
EPS Next 2YN/A
EPS Next 3YN/A
NOM Yearly Income VS Free CF VS DividendNOM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M
NOM Dividend Payout.NOM Dividend Payout, showing the Payout Ratio.NOM Dividend Payout.PayoutRetained Earnings

NUVEEN MO QLTY MUNI INC

NYSE:NOM (7/15/2025, 8:08:18 PM)

After market: 11.7 +0.44 (+3.91%)

11.26

+0.56 (+5.23%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners10.72%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.46M
Analysts0
Price TargetN/A
Short Float %0.14%
Short Ratio0.6
Dividend
Industry RankSector Rank
Dividend Yield 7.57%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP85.63%
Div Incr Years1
Div Non Decr Years1
Ex-Date06-13 2025-06-13 (0.0675)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.56
Fwd PE N/A
P/S 13.5
P/FCF 13.3
P/OCF 13.3
P/B 0.98
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)0.68
EY6.04%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.85
FCFY7.52%
OCF(TTM)0.85
OCFY7.52%
SpS0.83
BVpS11.49
TBVpS11.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.48%
ROE 5.93%
ROCE 1.42%
ROIC 1.12%
ROICexc 1.12%
ROICexgc 1.12%
OM 33.16%
PM (TTM) 81.63%
GM 36.22%
FCFM 101.53%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.54%
OM growth 5Y-9.1%
PM growth 3Y-29.59%
PM growth 5Y-15.05%
GM growth 3Y-17.51%
GM growth 5Y-8.59%
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 9.55
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.79
Cash Conversion N/A
Profit Quality 124.38%
Current Ratio 0.43
Quick Ratio 0.43
Altman-Z 1.7
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.89%
EPS 3Y-29.56%
EPS 5Y-16.18%
EPS Q2Q%133.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.41%
Revenue growth 3Y0.34%
Revenue growth 5Y-1.28%
Sales Q2Q%1.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.16%
EBIT growth 3Y-18.26%
EBIT growth 5Y-10.26%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y128.74%
FCF growth 3Y-28.77%
FCF growth 5Y-12.74%
OCF growth 1Y128.74%
OCF growth 3Y-28.77%
OCF growth 5Y-12.74%